IGF1 and atherosclerosis: Recent research suggests that IGFBP-3 secretion by senescent cells in the fibrous cap antagonizes IGF-I-mediated switching of VSMCs from a contractile to a promigratory state, leading to speculation that inhibiting IGFBP-3 action might be of therapeutic benefit in atherosclerosis [120].